Skip to main content
Log in

Epidural leukemic involvement and intracranial hemorrhage as initial manifestations in a newly diagnosed chronic myeloid leukemia patient

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Takayama N, Sato N, O’Brien SG, Ikeda Y, Okamoto S (2002) Imatinib mesylate has limited activity against the central nervous system involvement of Philadelphia chromosome-positive acute lymphoblastic leukaemia due to poor penetration into cerebrospinal fluid. Br J Haematol 119(1):106–108. doi:3881

    Article  PubMed  Google Scholar 

  2. Petzer AL, Gunsilius E, Hayes M, Stockhammer G, Duba HC, Schneller F, Grunewald K, Poewe W, Gastl G (2002) Low concentrations of sti571 in the cerebrospinal fluid: a case report. Br J Haematol 117(3):623–625. doi:3523

    Article  PubMed  Google Scholar 

  3. Senior K (2003) Gleevec does not cross blood–brain barrier. Lancet Oncol 4(4):198. doi:S1470204503010507

    Article  PubMed  Google Scholar 

  4. Wolff NC, Richardson JA, Egorin M, Ilaria RL Jr (2003) The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr/Abl-induced leukemia. Blood 101(12):5010–5013. doi:10.1182/blood-2002-10-30592002-10-3059

    Article  PubMed  CAS  Google Scholar 

  5. Bornhauser M, Jenke A, Freiberg-Richter J, Radke J, Schuler US, Mohr B, Ehninger G, Schleyer E (2004) CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid. Ann Hematol 83(6):401–402. doi:10.1007/s00277-003-0829-4

    Article  PubMed  Google Scholar 

  6. Rytting ME, Wierda WG (2004) Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy. Leuk Lymphoma 45(8):1623–1626. doi:10.1080/104281904100016677036DWB2RT2HEFWNKGT

    Article  PubMed  Google Scholar 

  7. Leis JF, Stepan DE, Curtin PT, Ford JM, Peng B, Schubach S, Druker BJ, Maziarz RT (2004) Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with imatinib (STI-571). Leuk Lymphoma 45(4):695–698

    Article  PubMed  CAS  Google Scholar 

  8. Altintas A, Cil T, Kilinc I, Kaplan MA, Ayyildiz O (2007) Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report. J Neurooncol 84(1):103–105. doi:10.1007/s11060-007-9352-0

    Article  PubMed  Google Scholar 

Download references

Authors’ disclosures of potential conflicts of interest

The author(s) have no potential conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chao-Sung Chang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cho, SF., Liu, TC., Lu, CY. et al. Epidural leukemic involvement and intracranial hemorrhage as initial manifestations in a newly diagnosed chronic myeloid leukemia patient. Ann Hematol 90, 607–609 (2011). https://doi.org/10.1007/s00277-010-1061-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-010-1061-7

Keywords

Navigation